According to the reporter's interview, this product is actually an ordinary "far-infrared pain-relieving patch", which only has an auxiliary treatment effect on pain, and its advertisements are suspected of false propaganda and many other illegal acts. At present, due to the alleged publication of false advertisements, the "Zhang lame plaster" may face investigation by the regulatory authorities.
Complaint: The advertisement of "Zhang Cripple Plaster" went viral
Consumers reported that in July this year, they saw through TV advertisements that a product called "Zhang Cripple Plaster" could cure all kinds of rheumatic bone diseases. The product in the advertising language has an amazing effect, claiming that it is made from the secret recipe of 89 Chinese herbal medicines handed down from generation to generation through "three steaming, nine boiling, seven fire and five cooling" micro-needle locking medicine punching and drying. The inventor even claimed that the plaster has a unique skill in treating rheumatic osteopathy, which can penetrate seven layers of bones and pull out poison to repair and prevent recurrence. The wild medicinal materials in Changbai Mountain are used, and the volcanic magnet in Changbai Mountain is added as the medicine-penetrating guide, just like "delivering medicine through a rocket", which penetrates seven layers, one paste ensures that the bone does not hurt, and then paste it to ensure that the tendons do not hurt, and three or four pastes can move all around the neck, shoulders, waist and legs to bid farewell to rheumatic osteopathy. It can quickly treat cervical spondylosis, lumbar disc herniation, hyperosteogeny, degenerative changes, scapulohumeral periarthritis, ankylosing spondylitis, rheumatism, rheumatoid arthritis, lumbar muscle strain, femoral head necrosis, joint swelling and deformation, fracture, various traumatic injuries, puerperal wind and other rheumatic bone diseases.
"The advertisement also said that the top 5 callers can get half price, so I spent nearly 1, yuan on two boxes. However, after using it for one month, I didn't feel anything except a little hot, let alone pain relief and treatment. At that time, I felt cheated. " Mr. Luo said in an interview.
on the product description of "Zhang lame plaster" provided by the complainant, the reporter saw that "Zhang lame plaster" was the trademark name, while the product was actually called "Far-infrared analgesic plaster". The trademark holder was "Anshan Zhongyi Tongying Pharmaceutical Investment Co., Ltd." and the manufacturer was "Anhui Zhongkang Pharmaceutical Co., Ltd.". According to the reporter's inquiry, this plaster is made by evenly mixing medical adhesive paste or medical hot melt adhesive with a certain proportion of far-infrared ceramic powder and coating it on elastic fabric, white plain cloth or non-woven fabric to prevent it from sticking to isolation paper. It mainly uses the warm effect generated by far-infrared ray emitted by far-infrared ceramic powder with a certain wavelength to improve microcirculation, promote blood circulation and enhance the vitality of organism cells, which is inconsistent with the role of advertising.
The query network found that "Zhang Cripple Plaster" had been punished before: in 219, it was investigated and punished by the market supervision department of Qidong County, Hunan Province, and fined 132, yuan for allegedly violating the advertising law because of the objective, untrue and wanton exaggeration and false description of the efficacy in the published advertisement.
unannounced visit: the promotion of "89 Chinese herbal medicines" actually does not contain any Chinese herbal ingredients
On September 21st, the reporter went to Anhui Zhongkang Pharmaceutical Co., Ltd. located in Yingdong Economic and Technological Development Zone, Fuyang City, Anhui Province for an unannounced visit.
In the sales department on the third floor, a salesperson surnamed Yao said after seeing the packaging box of "Zhang Lame Plaster" provided by the reporter that the product was an OEM product produced by the company in batches according to the needs of dealers. Regarding the specific work and responsibility distribution, the salesperson revealed that the production enterprise is responsible for the advertising approval procedures, and the advertising broadcast content is produced by the sales company itself. Regarding the therapeutic effect of "Zhang lame plaster", the staff said: "The product is a medical device, with no medicinal ingredients, and only mint is added at most, which is an auxiliary function for pain treatment." According to the staff member, the sole distributor of "Zhang lame plaster" is a company in Northeast China, and the specific situation is not clear because it is not the customer directly responsible for it.
The reporter noticed that there were several boxes of "Zhang Gai Zi Plaster" samples in the office.
Anhui Fuyang Yingdong Market Supervision Bureau: It is inconsistent with the approved examination contents
As a local supervision department, has Anhui Fuyang Yingdong Market Supervision Bureau conducted effective daily supervision on this enterprise? Do you know that the company has exaggerated propaganda and other behaviors?
On September 21st, with these questions, the reporter came to Fuyang Yingdong Market Supervision Bureau for an interview. Regarding the relevant questions interviewed by reporters, Tian Kechang of the Supervision Department of the Bureau said that he would give a written reply to reporters after the investigation.
On September 23rd, Yingdong District Market Supervision Administration of Fuyang City, Anhui Province sent the reporter a document entitled "Reply on Reporting the Suspected False Propaganda and Verification of Anhui Zhongkang Pharmaceutical Co., Ltd.".
The reply stated that the far-infrared pain-relieving plaster product produced by Anhui Zhongkang Pharmaceutical Co., Ltd. was marked with "Zhang Cricket". The manufacturer was Anhui Zhongkang Pharmaceutical Co., Ltd., the production address was No.3 Dongxing Road, Yingdong Economic Development Zone, Fuyang City, and the production license number was No.21726 of Anhui Food and Drug Administration. This product belongs to the second-class medical device and was called "Zhang Cricket Plaster" in the report letter.
The far-infrared analgesic plaster products produced by Anhui Zhongkang Pharmaceutical Co., Ltd. are licensed by Anshan Zhongyi Tongying Pharmaceutical Investment Co., Ltd., and both parties have signed a trademark license contract, and it is clear in the sales contract that Anshan Zhongyi Tongying Pharmaceutical Investment Co., Ltd. is the sole distributor, and it is not allowed to exaggerate the publicity by advertising. If the advertising exaggerates the publicity, all consequences will be at your own risk.
Anshan Zhongyi Tongying Pharmaceutical Investment Co., Ltd. is the sole distributor of "Zhang Gai Zi" far-infrared pain-relieving plaster products. During the sales process between the two parties, Anhui Zhongkang Pharmaceutical Co., Ltd. provided the company with the Decision on Approval of Advertising Examination by Anhui Provincial Market Supervision Administration (Wan Guang Shen Permission Zi [22] No.22), but did not entrust the company to carry out product advertising. The advertisement video pictures released by law enforcement officers in the mass media through the Consumer Daily reporter's "Zhang Cripple Plaster" were compared with the contents of the advertisement review (No.22 [22]), and it was found that the propaganda contents in the video advertisement pictures and a large number of advertisements labeled as "Zhang Cripple Plaster" did not match the contents of the advertisement review.
The verification reply also stated that Anhui Zhongkang Pharmaceutical Co., Ltd. stated in the "Description on False Propaganda of Zhang Quezi Brand Far-infrared Pain-relieving Sticker" submitted to the bureau on September 21, 22: "Our company has not entrusted any provincial, city and county radio and television stations, newspapers, magazines and other media to publish advertisements for this product. For media such as radio and TV stations that publish false advertisements of products without the authorization of our company, our company will investigate their relevant responsibilities according to law and earnestly safeguard our company's good image. "
according to paragraph 1 of article 28 of the interim measures for handling complaints and reports in market supervision and management, "reports of illegal advertisements published by mass media such as radio, movies, television, newspapers, periodicals and the internet shall be handled by the market supervision and management department where the advertisement publisher is located. If it is difficult for the market supervision and administration department where the advertisement publisher is located to handle reports to advertisers and advertising operators in different places, it may transfer the reports to the market supervision and administration department where the advertisers and advertising operators are located. "
suggestion in the reply letter: the whistleblower should report to the market supervision department of the place where the false propaganda behavior is suspected, and after the local market supervision department investigates and collects evidence, the clues of the case will be transferred to our bureau for investigation and verification.
the bureau provided a copy of Anhui zhongkang pharmaceutical co., ltd.' s business license, medical device production license, advertisement examination permission decision and trademark use license contract.
Liaoning Provincial Market Supervision Bureau: The column lecture is suspected of publishing illegal medical device advertisements in disguised form
According to the requirements of the relevant departments of Liaoning Provincial Market Supervision Bureau, on September 23rd, the reporter faxed the interview outline and other relevant interview materials to the Press and Publicity Department of Liaoning Provincial Market Supervision Bureau.
On September 29th, the person in charge of the Press and Publicity Department of Liaoning Provincial Market Supervision Bureau said in the "Explanation on Transferring the Monitoring Clues of" Zhang Lame Plaster "Advertising (pictured) that the advertising monitoring platform of the Provincial Bureau conducted a spot check in early September and found that the XX channel of Liaoning released a lecture on" Zhang Lame Plaster ",which was suspected of publishing medical device advertisements in disguised form by introducing health and health preservation knowledge. On September 2th, our bureau. On September 25th, a letter of supervision on illegal clues was issued to the advertising department of Shenyang Municipal Market Supervision Administration, requesting that the lecture on "Zhang Lame Plaster" be immediately organized to investigate and deal with the behavior of publishing medical device advertisements in disguised form by introducing health and health preservation knowledge. At the same time, Liaoning Radio and Television Station was issued with the Notice of Providing Materials within a Time Limit, requiring it to provide the relevant approval documents for the lecture on "Zhang lame plaster" and the relevant examination documents for the advertisement of medical devices. On September 25, the working mechanism of the joint meeting of the province to rectify false and illegal advertisements was implemented, and the monitoring of the suspected publication of illegal advertisements in the lecture on "Zhang lame plaster" was notified to Liaoning Radio and Television Bureau. At present, the spot check monitoring of the advertising monitoring platform of the provincial bureau has not found that the lecture of "Zhang lame plaster" continues to be broadcast.
The reporter inquired about Anshan Zhongyi Tongying Pharmaceutical Investment Co., Ltd. from the national enterprise credit information publicity system. On September 27, the reporter called the company to disclose its contact information, but the phone has been unable to connect. After the reporter sent the interview materials according to its registered address, it also showed that the sending was unsuccessful.